ROLE OF VITAMIN C AND VITAMIN E ON HYPERTENSION
Objective: Both Vitamin C and Vitamin E supplementation were associated with reduction in blood pressure (BP) in observational studies, although, results of clinical trials are inconsistent. The objective of our study is to conduct a clinical trial to observe the effects of oral supplementation of Vitamin C and Vitamin E on BP.
Methods: About 60 non-teaching staffs of our college with systolic BP more than 130 mmHg and diastolic BP more than 90 mmHg were taken as subjects and divided into two groups. Initial BP and BP after oral Vitamin C, 500 mg/day for a period of 12weeks to Group 1 and initial BP and BP after oral Vitamin E, 200 IU/day, for a period of 12 weeks to Group 2 were recorded.
Results: Statistical analysis was done by paired t-test, analysis of variance (ANOVA), and least significant difference (LSD) tests. *p<0.05 was considered statistically significant. Systolic 2 and diastolic 2 – after 3 months of supplementation showed 0.161 and 0.161 which is not significant. ANOVA and LSD tests show no significant results.
Conclusion: Long-term trials on the effects of Vitamin C and Vitamin E supplementation on BP and clinical events are needed.
2. Frei B, England L, Ames BN. Ascorbate is an outstanding antioxidant in human blood plasma. Proc Natl Acad Sci U S A 1989;86:6377-81.
3. Jackson TS, Xu A, Vita JA, Keaney JF Jr. Ascorbate prevents the interaction of superoxide and nitric oxide only at very high physiological concentrations. Circ Res 1998;83:916-22.
4. Hoiink AW. Research on the influence of Vitamin C administration on human organism, in particular in connection with the working capacity. Verh Nederlands Inst Praevent 1946;4:62-8.
5. Yoshioka M, Aoyama K, Matsushita T. Effects of ascorbic acid on blood pressure and ascorbic acid metabolism in spontaneously hypertensive rats (SH rats). Int J Vitam Nutr Res 1985;55:301-7.
6. Ettarh RR, Odigie IP, Adigun SA. Vitamin C lowers blood pressure and alters vascular responsiveness in salt-induced hypertension. Can J Physiol Pharmacol 2002;80:1199-202.
7. Koh ET. Effect of Vitamin C on blood parameters of hypertensive subjects. J Okla State Med Assoc 1984;77:177-82.
8. Feldman EB, Gold S, Greene J, Moran J, Xu G, Shultz GG, et al. Ascorbic acidsupplements and blood pressure: A four-week pilot study. Ann N Y Acad Sci 1992;669:342-4.
9. Moran JP, Cohen L, Greene JM, Xu G, Feldman EB, Hames CG, et al. Plasma ascorbic acid concentrations relate inversely to blood pressure in human subjects. Am J Clin Nutr 1993;57:213-7.
10. McCarron DA, Morris CD, Henry HJ, Stanton JL. Blood pressure and nutrient intake in the United States. Science 1984;224:1392-8.
11. Sherman DL, Keaney JF Jr., Biegelsen ES, Duffy SJ, Coffman JD, Vita JA, et al. Pharmacological concentrations of ascorbic acid are required for the beneficial effect on endothelial vasomotor function in hypertension. Hypertension 2000;35:936-41.
12. Xu A, Vita JA, Keaney JF Jr. Ascorbic acid and glutathione modulate the biological activity of S-nitrosoglutathione. Hypertension 2000;36:291-5.
13. Newaz MA, Nawal NN. Effect of alpha-tocopherol on lipid peroxidation and total antioxidant status in spontaneously hypertensive rats. Am J Hypertens 1998;11:1480-5.
14. Newaz MA, Nawal NN, Rohaizan CH, Muslim N, Gapor A. Alpha-tocopherol increased nitric oxide synthase activity in blood vessels of spontaneously hypertensive rats. Am J Hypertens 1999;12:839-44.
15. Taddei S, Virdis A, Ghiadoni L, Magagna A, Salvetti A. Vitamin C improves endothelium-dependent vasodilation by restoring nitric oxide activity in essential hypertension. Circulation 1998;97:2222-9.
16. Chaudière J, Ferrari-Iliou R. Intracellular antioxidants: From chemical to biochemical mechanisms. Food Chem Toxicol 1999;37:949-62.
17. Suematsu N, Ojaimi C, Recchia FA, Wang Z, Skayian Y, Xu X, et al. Potential mechanisms of low-sodium diet-induced cardiac disease: Superoxide-NO in the heart. Circ Res 2010;106:593-600.
18. Duffy SJ, Gokce N, Holbrook M, Huang A, Frei B, Keaney JF Jr., et al. Treatment of hypertension with ascorbic acid. Lancet 1999;354:2048-9.
19. Santoro D, Caccamo D, Lucisano S, Buemi M, Sebekova K, Teta D, et al. Interplay of Vitamin D, erythropoiesis, and the renin-angiotensin system. Biomed Res Int 2015;2015:145828.
20. Khaw KT, Bingham S, Welch A, Luben R, Wareham N, Oakes S, et al. Relation between plasma ascorbic acid and mortality in men and women in EPIC-norfolk prospective study: A prospective population study. European prospective investigation into cancer and nutrition. Lancet 2001;357:657-63.
21. Palumbo G, Avanzini F, Alli C, Roncaglioni MC, Ronchi E, Cristofari M, et al. Effects of Vitamin E on clinic and ambulatory blood pressure in treated hypertensive patients. Collaborative group of the primary prevention project (PPP) hypertension study. Am J Hypertens 2000;13:564-7.
22. Srivatsan R, Das S, Gadde R, Manoj-Kumar K, Taduri S, Rao N, et al. Antioxidants and lipid peroxidation status in diabetic patients with and without complications. Arch Iran Med 2009;12:121-7.
23. Paolisso G, D’Amore A, Giugliano D, Ceriello A, Varricchio M, D’Onofrio F, et al. Pharmacologic doses of Vitamin E improve insulin action in healthy subjects and non-insulin-dependent diabetic patients. Am J Clin Nutr 1993;57:650-6.
24. Iqbal S, Naseem I. Role of Vitamin A in Type 2 diabetes mellitus biology: Effects of intervention therapy in a deficient state. Nutrition 2015;31:901-7.
25. Reaven PD, Herold DA, Barnett J, Edelman S. Effects of Vitamin E on susceptibility of low-density lipoprotein and low-density lipoprotein subfractions to oxidation and on protein glycation in NIDDM. Diabetes Care 1995;18:807-16.
26. Omar GN, Al-Arabi FY, Mehdi MA, Fawade MM. Antioxidant effect of Vitamins combined A, C, and E dose on Type 2 Diabetic patients. Asian J Pharm Clin Res 2019;12:51-4.
27. Nugrahaningsih DA, Sholikhah EN, Mustofa M, Yuliani FS, Purwono S, Ngatidjan N, et al. Blood pressure lowering effect of polyherbal preparation containing Allium sativum, Bellerica efructus, Curcuma aeruginosa, and amomifructus on rat model of hypertension. Asian J Pharm Clin Res 2019;12:311-4.
This work is licensed under a Creative Commons Attribution 4.0 International License.
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.